Abstract
A phase I trial was performed to determine the toxicity and efficacy of isolated hepatic perfusion with tumour necrosis factorα (TNF) and melphalan (Alkeran) under mild hyperthermic conditions. Eleven patients with unresectable metastatic malignancies in the liver (malignant melanoma, leiomyosarcoma, colorectal cancer) underwent the procedure. Compared to our earlier experience with melphalan and cis-platinum under hyperthermic conditions (41.7 °C), this phase I study with TNF 30–200 μg and melphalan 0.5 mg/kg body weight under 39 °C hyperthermia neither improved the response rate nor decreased the serious adverse effects. Two patients died within the first postoperative month owing to coagulopathy or multiple organ failure. Five patients were reoperated owing to postoperative bleeding. Three of six patients with liver metastases from malignant melanoma or leiomyosarcoma and none of five patients with liver metastases from colorectal cancer showed a partial response.
Supported by grants from the Swedish Medical Research Foundation (grant K97-17X-07184-13A) and the Swedish Cancer Society (grant 1081-B96-11XAB). TNFα was kindly supplied by Hans Kierulff-Nielsen, Interferon Research Institute, Hjörring, Denmark.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aigner KR, Walther H, Tonn J, Wenzl A, Hechtel R, Merker G, Schwemmle K (1983) First experimental and clinical results of isolated hepatic perfusion with cytotoxics in metastases from colorectal primary. Recent Results Cancer Res 86: 99–102
Aigner KR, Walther H, Link KH (1988) Isolated liver perfusion with MMC/5-Fu: surgical technique, pharmacokinetics, clinical results. Contrib Oncol 29: 229–246
Ausman RK (1961) Development of a technic for isolated perfusion of the liver. NY State J Med 61: 3993–3997
Ausman RK, Aust JB (1960) Isolated perfusion of the liver with HN2. Surg Forum 10: 77
Aust JB, Ausman RK (1960) The technique of liver perfusion. Cancer Chemother Rep 10: 23–33
Hafstrom L, Mattson J (1993) Regional chemotherapy for malignant melanoma. Cancer Treat Rev 19: 17–28
Hafström L, Holmberg SB, Naredi P, Lindnér PG, Bengtsson A, Tidebrant G, Scherstén T (1994 a) Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 3: 103–108
Hafström L, Holmberg SB, Lindnér PL, Naredi P, Asztely M, Bengtsson A, Nielsen HK, Scherstén T (1994 b) Isolated regional liver perfusion with tumour necrosis factor-alpha followed by hyperthermic melphalan perfusion. Reg Cancer Treat 7: 172–176
Healey JE (1960) The technique of liver perfusion. Cancer Chemother Rep 10: 24
Healey JE, Smith JL, Clark RL, Stehlin JS, White EG (1961) Hepatic tissue tolerance to thio-TEPA administered by the isolation-perfusion technique. J Surg Res 1: 111–116
Jaskowiak NT, Alexander HR, Bartlett DL, Turner EM, Tsigos C, Papanicolaou D, Chrousos GP, Fraker DL (1996) Secondary cytokine production and endocrine effects after high dose intravascular TNF. In: Fraker DL, Jacobsen SE (eds) TNF and related cytokines: clinical utility and biology of action. Cambridge Symposia, Hilton Head Island, South Carolina, p 8
Lienard D, Lejeune FJ, Ewalenko P (1992) In transit metastases of malignant melanoma treated by high dose rTNF-alpha in combination with interferon-gamma and melphalan in isolation perfusion. World J Surg 16: 234–240
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Hafström, L., Naredi, P. (1998). Isolated Hepatic Perfusion with Extracorporeal Oxygenation Using Hyperthermia TNFα and Melphalan: Swedish Experience. In: Oldhafer, K.J., Lang, H., Pichlmayr, R. (eds) Isolated Liver Perfusion for Hepatic Tumors. Recent Results in Cancer Research, vol 147. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80460-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-80460-1_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80462-5
Online ISBN: 978-3-642-80460-1
eBook Packages: Springer Book Archive